Historical record - last NADAC effective date: 1/22/2020
Product Information
ZORTRESS 0.5 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $17.8041 per EA under NDC 00078041420. Its NADAC has been published 344 times since Jun 18, 2014.
FDA first approved this application on Apr 20, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the everolimus market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078041420
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
1/22/2020
Active Ingredients
EVEROLIMUSApproval Type
New Drug (NDA)
FDA Application
NDA021560FDA Approved
4/20/2010
TE Code
AB
On Market Since
4/22/2010
Pharmacological Classes
Price Statistics
The NADAC for ZORTRESS 0.5 MG TABLET has been published 344 times since Jun 18, 2014, and over the history we have for it it has risen 39.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.8041 per EA |
|---|---|
| All-time high | $17.8730 (Jan 15, 2020) |
| All-time low | $12.7813 (Jun 18, 2014) |
| Median price | $15.8542 |
| Average price | $15.5752 |
| Largest weekly change | +7.0% (Jul 15, 2015) |
| Weeks tracked | 344 |
| Tracking since | Jun 18, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+39.3%
Last surveyed Jan 13, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the everolimus market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZORTRESS 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZORTRESS 0.5 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $17.8041 per EA (NDC 00078041420), effective Jan 13, 2021.
How has the price of ZORTRESS 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZORTRESS 0.5 MG TABLET has risen 39.3%. It has been tracked across 344 weekly CMS publications since Jun 18, 2014.
What are the highest and lowest recorded NADAC prices for ZORTRESS 0.5 MG TABLET?
Since Jun 18, 2014, the NADAC for ZORTRESS 0.5 MG TABLET has ranged from a low of $12.7813 (Jun 18, 2014) to a high of $17.8730 (Jan 15, 2020), with a median of $15.8542 per EA.
Are there cheaper alternatives to ZORTRESS 0.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ZORTRESS 0.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZORTRESS 0.5 MG TABLET?
ZORTRESS 0.5 MG TABLET (NDC 00078041420) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.